Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
Clinical trial NCT04009057 · COMPLETED
Trial details
- NCT number
- NCT04009057
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-07-09
- Primary completion
- 2022-03-21
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.